Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications.
about
Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesisRoles of arrest-defective protein 1(225) and hypoxia-inducible factor 1alpha in tumor growth and metastasisAntiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells.DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFAAACR centennial series: the biology of cancer metastasis: historical perspectiveA pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancerTargeting IL-8 in colorectal cancer.Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.Demonstration and biological significance of a gastrin-P21-activated kinase 1 feedback loop in colorectal cancer cellsInhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon SystemSilibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules.Recent advances in the management of carcinoma of the rectumDeciphering genomic alterations in colorectal cancer through transcriptional subtype-based network analysisHeterogeneity of Tie2 expression in tumor microcirculation: influence of cancer type, implantation site, and response to therapy.Emerging drugs for non-small cell lung cancer.Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity.Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma.Cyclooxygenase-2 expression and angiogenesis in colorectal cancer.Hypoxia and angiogenesis in pancreatic cancer.Antiangiogenic therapy in human gastrointestinal malignancies.Tumour-associated angiogenesis in human colorectal cancer.Effect of Blocking of Neuropeptide Y Y2 Receptor on Tumor Angiogenesis and Progression in Normal and Diet-Induced Obese C57BL/6 Mice.The new paradigm in the treatment of colorectal cancer: are we hitting the right target?Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.The immunopharmacologic potential of Semaxanib and new generation directed therapeutic drugs: Receptor tyrosine kinase regulation with anti-tumorigenensis/angiogenesis properties.Vascular targeted therapies in oncology.Bevacizumab in the therapy for refractory metastatic colorectal cancer.Clinical use of anti-vascular endothelial growth factor monoclonal antibodies in metastatic colorectal cancer.Antiangiogenic and antitumoral effects mediated by a vascular endothelial growth factor receptor 1 (VEGFR-1)-targeted DNAzyme.Angiogenesis factors involved in the pathogenesis of colorectal cancer.Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.Amino acid metabolism related to immune tolerance by MDSCs.Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer.Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.Combined therapeutic effects of vinblastine and Astragalus saponins in human colon cancer cells and tumor xenograft via inhibition of tumor growth and proangiogenic factors.Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer.C-Glycosyl Flavonoids from Beta vulgaris Cicla and Betalains from Beta vulgaris rubra: Antioxidant, Anticancer and Antiinflammatory Activities-A Review.Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems.
P2860
Q28263245-836D98B3-EB18-4DC3-AD19-979364ACC083Q28274705-3CA72BCC-38CD-4D26-9DE1-2ED9DFA7C12EQ30474689-ED73E004-EE63-4972-93C6-9CDFE4ED37F7Q33509884-56E3F1B0-03FC-4592-83EE-B78F125FDD4BQ33603626-A33ED4F2-1992-477F-B267-8AB8D9C6C10BQ33683443-4F8221AF-924E-499D-AE89-7BED102EE7EDQ34224045-D29EC86B-38B3-4406-8BEE-54CFE594D3ECQ34267408-776BB305-ACC2-4D97-A7D4-04AFDF9987A6Q34367591-8663A6CE-810B-4765-9057-BDD22258D1C4Q34399985-DF344B61-31DF-4339-B6A2-BB4FA1BFF596Q34608072-EB7BD751-6203-4A11-8217-A9E7F0EB8BC4Q34902676-0C31D100-8C08-4A78-B198-4E48F918D846Q35026254-23AE8E25-EFC5-4B36-9543-C1B48F5AC1EDQ35048299-26E16E6C-DFBE-4EC9-B1FF-C84E4D12CAEEQ35094428-CA5CFDFF-54AA-4F34-8FEC-5B48CDA1DB9FQ35581167-6A855B5C-39F6-4F10-8887-283C8151C312Q35587630-B92A2098-3DDB-461C-9F5D-8B196D770996Q35610708-6B040A6E-61DA-4795-ACCA-57302DAD4EF2Q35740177-C2E0728A-98C6-45F0-ACEA-5E5CDC603E20Q36179801-9A32AE76-5140-47B1-8E23-8C3642BEF57EQ36572752-698E2DCF-1DBE-4BC0-8044-FFB124679AA9Q36591067-A184337F-4E06-4B4D-874B-83E88B2F63BAQ36689348-BE1D5672-0E6C-4F3A-93DC-4ED2B36FE0CEQ36718477-245B2E85-C8D3-4AB7-BD99-BD5ACA0AE06FQ36736346-6277E2A9-9DD0-4F89-930C-9FF86201F329Q36764012-309B9D93-E737-4738-BE22-987C6783D50EQ37098747-AE93FB1D-4FC8-49F3-9F88-42056FF04838Q37254370-1FFB8663-0B93-4D80-9D0F-1AAB6D4ED892Q37307590-82FA0B11-4CA0-4F61-A3E6-50E32D5B8687Q37316035-ADCBFF84-3884-4E93-8079-EB2C9C9BFEC7Q37446015-4F0EB642-AD82-48A9-BEC9-D2E32BFB461CQ37735575-45D90FBB-237F-46F6-838B-07CA5DDCE8E2Q37747100-E83F61EB-3808-49F0-8616-022BCC242E91Q38010200-50C9E524-2BA9-442A-A393-E77C375A742CQ38171332-8F2DC0E1-9BEB-4AB1-998D-C2EBFDE37EDAQ38594420-3FD819CC-D327-47CA-99CE-435FF41664DBQ39012529-F422C58F-AEF9-4D47-9A02-82FF7BA81AECQ39036253-F1A6910A-C506-4EDA-BAB7-8C17FEAE7887Q39278666-76BE4333-07DB-4845-97A9-6F6AFDA4B8B6Q39785586-B94FF5E5-BEBB-472A-AA0F-58EF23A2D9B3
P2860
Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Vascular endothelial growth fa ...... and therapeutic implications.
@ast
Vascular endothelial growth fa ...... and therapeutic implications.
@en
Vascular endothelial growth fa ...... and therapeutic implications.
@nl
type
label
Vascular endothelial growth fa ...... and therapeutic implications.
@ast
Vascular endothelial growth fa ...... and therapeutic implications.
@en
Vascular endothelial growth fa ...... and therapeutic implications.
@nl
prefLabel
Vascular endothelial growth fa ...... and therapeutic implications.
@ast
Vascular endothelial growth fa ...... and therapeutic implications.
@en
Vascular endothelial growth fa ...... and therapeutic implications.
@nl
P2093
P1433
P1476
Vascular endothelial growth fa ...... and therapeutic implications.
@en
P2093
P356
10.1634/THEONCOLOGIST.5-SUPPL_1-11
P478
P577
2000-01-01T00:00:00Z